Dystrophia Myotonica
Showing 1 - 9 of 9
Myotonic Dystrophy, Congenital Myotonic Dystrophy, Myotonic Dystrophy 1 Trial in Oakland (Patient-entered data)
Recruiting
- Myotonic Dystrophy
- +15 more
- Patient-entered data
-
Oakland, CaliforniaMyotonic Dystrophy Foundation
Oct 31, 2022
Myotonic Dystrophy Type 1 (DM1) Trial in Auckland (DYNE-101, Placebo)
Not yet recruiting
- Myotonic Dystrophy Type 1 (DM1)
- DYNE-101
- Placebo
-
Auckland, New ZealandUniversity of Auckland Research Centre
Jul 28, 2022
Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib, Placebo)
Recruiting
- Congenital Myotonic Dystrophy
- Tideglusib
- Placebo
-
Little Rock, Arkansas
- +14 more
Aug 11, 2022
DM1 Patients in China
Enrolling by invitation
- Myotonic Dystrophy 1
- Brain MRI scan
-
Shanghai, ChinaHuashan Hospital
Oct 20, 2023
Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib)
Enrolling by invitation
- Congenital Myotonic Dystrophy
-
Little Rock, Arkansas
- +10 more
Nov 15, 2021
Myotonic Dystrophy Trial in Newcastle Upon Tyne (Patient Registry)
Unknown status
- Myotonic Dystrophy
- Patient Registry
-
Newcastle Upon Tyne, United KingdomJohn Walton Muscular Dystrophy Research Centre
Oct 5, 2020
Muscular Dystrophies Trial (Structured self-management-training)
Withdrawn
- Muscular Dystrophies
- Structured self-management-training
- (no location specified)
Aug 14, 2019
Muscular Diseases -Pompe Disease and Dystrophia Myotonica-
Unknown status
- Glycogen Storage Disease Type 2
- Dystrophia Myotonica
-
Aarhus C, Denmark
- +1 more
Mar 9, 2016
Dystrophia Myotonica 1 Trial in Quebec (Methylphenidate, Placebo)
Completed
- Dystrophia Myotonica 1
- Methylphenidate
- Placebo
-
Quebec, CanadaInstitute of Readaptation in Physical Deficiency
Aug 22, 2011